Review articlePublished 2019
TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C AND B
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Summary. A number of clinical and population-based studies have shown a link between the development of insulin resistance and type 2 diabetes mellitus and hepatitis C.Purpose of research:to study the frequency of type 2 diabetes mellitus and its course in patients with chronic viral hepatitis C and B during antiviral therapy.Material and methods:213 patients (164 with CVH C, 34 with CVH B and 15 with CVH B + C) were examined before and in the course of treatment. All patients received standard antiviral therapy. In patients with type 2 diabetes, the level of fastingglycemiawas determined daily in the first 8-12 weeks of treatment. The level of glycemia was determined at the laboratory at least once every 2 weeks. Glycated hemoglobin was determined every 3 months during treatment and another 6 months after completion of the antiviral therapy.Results: In the group of patients with CVH C, type 2 diabetes mellitus occurred 2 times more often (13.4%) than in groups with CVH B (6.1%) with a reliability of p <0.01. With HCV genotype 3 is 2.5 times more often than with genotype 1 (p <0.001). Among patients, type 2 diabetes is 2.5 times more often men than women (p <0.01).Upon reaching an early virological response in 77.3% of patients, the level of glycemia returned to normal. The correlation coefficient between the achievement of a full virological response (negative PCR results on HCV RNA) and the normalization of the level of glycemia was 0.75. Glycemia control was maintained for 6 months after the completion of the antiviral therapy in the background of a persistent virological response.Conclusions:The presence of diabetes is the basis for screening for HCV, regardless of other factors. 75-77% of type 2 diabetes mellitus in the cohort of patients with CVH C is possibly virus-associated. Treatment of HCV infection can lead to a cure for type 2 diabetes mellitus in this category of patients.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSystematic Reviews in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “NIGORA AKESHOVA”
- BylineArticles whose byline prints “GAUKHAR KURMANOVA”
- BylineArticles whose byline prints “ALMAGUL KURMANOVA”
- BylineArticles whose byline prints “IKILAS MOLDALIEV”